234 related articles for article (PubMed ID: 32687679)
1. Epithelioid glioblastoma with microglia features: potential for novel therapy.
Nakagomi N; Sakamoto D; Hirose T; Takagi T; Murase M; Nakagomi T; Yoshimura S; Hirota S
Brain Pathol; 2020 Nov; 30(6):1119-1133. PubMed ID: 32687679
[TBL] [Abstract][Full Text] [Related]
2. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity.
Nakajima N; Nobusawa S; Nakata S; Nakada M; Yamazaki T; Matsumura N; Harada K; Matsuda H; Funata N; Nagai S; Nakamura H; Sasaki A; Akimoto J; Hirato J; Yokoo H
Brain Pathol; 2018 Sep; 28(5):663-673. PubMed ID: 29105198
[TBL] [Abstract][Full Text] [Related]
3. Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma.
Matsumura N; Nakajima N; Yamazaki T; Nagano T; Kagoshima K; Nobusawa S; Ikota H; Yokoo H
Neuropathology; 2017 Feb; 37(1):58-63. PubMed ID: 27302309
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of a BRAF V600E-mutant epithelioid glioblastoma patient by vemurafenib: a case report.
Lin Z; Xu H; Yang R; Li Z; Zheng H; Zhang Z; Peng J; Zhang X; Qi S; Liu Y; Huang G
Anticancer Drugs; 2022 Jan; 33(1):100-104. PubMed ID: 34232949
[TBL] [Abstract][Full Text] [Related]
5. Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
Kanemaru Y; Natsumeda M; Okada M; Saito R; Kobayashi D; Eda T; Watanabe J; Saito S; Tsukamoto Y; Oishi M; Saito H; Nagahashi M; Sasaki T; Hashizume R; Aoyama H; Wakai T; Kakita A; Fujii Y
Acta Neuropathol Commun; 2019 Jul; 7(1):119. PubMed ID: 31345255
[TBL] [Abstract][Full Text] [Related]
6. Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation.
Tanaka S; Nakada M; Nobusawa S; Suzuki SO; Sabit H; Miyashita K; Hayashi Y
Brain Tumor Pathol; 2014 Jul; 31(3):172-6. PubMed ID: 24894018
[TBL] [Abstract][Full Text] [Related]
7. A case of osteoclast-like giant cell-rich epithelioid glioblastoma with BRAF V600E mutation.
Funata N; Nobusawa S; Yamada R; Shinoura N
Brain Tumor Pathol; 2016 Jan; 33(1):57-62. PubMed ID: 26602910
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and molecular genetic study on epithelioid glioblastoma: Series of seven cases with review of literature.
Khanna G; Pathak P; Suri V; Sharma MC; Chaturvedi S; Ahuja A; Bhardwaj M; Garg A; Sarkar C; Sharma R
Pathol Res Pract; 2018 May; 214(5):679-685. PubMed ID: 29615337
[TBL] [Abstract][Full Text] [Related]
9. BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation.
Kleinschmidt-DeMasters BK; Aisner DL; Foreman NK
Am J Surg Pathol; 2015 Apr; 39(4):528-40. PubMed ID: 25581727
[TBL] [Abstract][Full Text] [Related]
10. Cerebellar glioblastoma: a clinical series with contemporary molecular analysis.
Hong B; Banan R; Christians A; Nakamura M; Lalk M; Lehmann U; Hartmann C; Krauss JK
Acta Neurochir (Wien); 2018 Nov; 160(11):2237-2248. PubMed ID: 30203362
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid/rhabdoid glioblastoma: a highly aggressive subtype of glioblastoma.
Sugimoto K; Ideguchi M; Kimura T; Kajiwara K; Imoto H; Sadahiro H; Ishii A; Kawano H; Ikeda E; Suzuki M
Brain Tumor Pathol; 2016 Apr; 33(2):137-46. PubMed ID: 26667174
[TBL] [Abstract][Full Text] [Related]
12. Epithelioid GBMs show a high percentage of BRAF V600E mutation.
Kleinschmidt-DeMasters BK; Aisner DL; Birks DK; Foreman NK
Am J Surg Pathol; 2013 May; 37(5):685-98. PubMed ID: 23552385
[TBL] [Abstract][Full Text] [Related]
13. Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study.
Xi S; Jiang S; Li H; Huang Q; Lu J; Zhang X; Li Z; Zeng J
Int J Cancer; 2024 Jul; 155(1):172-183. PubMed ID: 38411299
[TBL] [Abstract][Full Text] [Related]
14. Adult classical glioblastoma with a BRAF V600E mutation.
Takahashi Y; Akahane T; Sawada T; Ikeda H; Tempaku A; Yamauchi S; Nishihara H; Tanaka S; Nitta K; Ide W; Hashimoto I; Kamada H
World J Surg Oncol; 2015 Mar; 13():100. PubMed ID: 25885250
[TBL] [Abstract][Full Text] [Related]
15. Response to BRAF and MEK1/2 inhibition in a young adult with BRAF V600E mutant epithelioid glioblastoma multiforme: A Case Report and Literature Review.
Venkatesh A; Joshi A; Allinson K; Das T; Santarius T; Jefferies SJ; Harris FP; Jena R; Doherty GJ
Curr Probl Cancer; 2021 Oct; 45(5):100701. PubMed ID: 33461766
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma.
Furuta T; Miyoshi H; Komaki S; Arakawa F; Morioka M; Ohshima K; Nakada M; Sugita Y
Neuropathology; 2018 Jun; 38(3):218-227. PubMed ID: 29532523
[TBL] [Abstract][Full Text] [Related]
17. Effect of BRAF/MEK Inhibition on Epithelioid Glioblastoma with BRAFV600E Mutation: a Case Report and Review of the Literature.
Li Y; Yang S; Hao C; Chen J; Li S; Kang Z; Kang X; Zhang H; Li W
Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776753
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral heterogeneity of genomic imbalance in a case of epithelioid glioblastoma with BRAF V600E mutation.
Nobusawa S; Hirato J; Kurihara H; Ogawa A; Okura N; Nagaishi M; Ikota H; Yokoo H; Nakazato Y
Brain Pathol; 2014 Apr; 24(3):239-46. PubMed ID: 24354918
[TBL] [Abstract][Full Text] [Related]
19. The Significance of
Prieto R; Barrios L; Ebrat-Mancilla E; MartÃn P; Tejerina E
Int J Surg Pathol; 2024 Jun; 32(4):649-666. PubMed ID: 37743598
[TBL] [Abstract][Full Text] [Related]
20. A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.
Kuroda J; Nobusawa S; Nakamura H; Yokoo H; Ueda R; Makino K; Yano S; Kuratsu J
Neuropathology; 2016 Apr; 36(2):181-6. PubMed ID: 26375727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
